Regression valuation
Fit an ordinary least squares regression of a valuation multiple against a fundamental driver. Each company's residual quantifies how much it trades above or below where the comp set says it should. Inspired by Meritech's growth-adjusted multiple framework.Snapshot: 2026-08-04.
All sectorsApplication SoftwareInfrastructure & Data SoftwareCybersecurityFintechInternet & Digital CommerceConsumer Internet, Media & GamingHealthcare ServicesMedical Devices & DiagnosticsSemiconductorsPharma & BiotechIndustrial, Aerospace & DefenseFinancial ServicesBusiness ServicesUtilitiesEnergyMaterialsTransportationConsumer DiscretionaryConsumer StaplesReal EstateCommunications & Telecom
Universe: Medical Devices & Diagnostics · 20 companies
Model
y = -0.92·x + 3.83
n = 19 · R² = 0.006
Most undervalued vs. model
Trading below the regression line
| Ticker | Actual | Model | Residual |
|---|---|---|---|
| FUJIYFUJIFILM Holdings Corporation | 0.2x | 3.8x | -93.5% |
| QDELQuidelOrtho Corporation | 1.4x | 3.8x | -62.8% |
| SMMNYSiemens Healthineers AG | 1.5x | 3.7x | -59.3% |
| PHGKoninklijke Philips N.V. | 1.7x | 3.8x | -54.8% |
| GEHCGE HealthCare Technologies Inc. | 1.8x | 3.8x | -52.7% |
Most overvalued vs. model
Trading above the regression line
| Ticker | Actual | Model | Residual |
|---|---|---|---|
| TECHBio-Techne Corporation | 8.9x | 3.8x | 135.4% |
| ILMNIllumina, Inc. | 6.6x | 3.7x | 76.6% |
| DHRDanaher Corporation | 5.8x | 3.7x | 56.8% |
| AAgilent Technologies, Inc. | 5.2x | 3.7x | 40.8% |
| TMOThermo Fisher Scientific Inc. | 5.1x | 3.7x | 35.5% |